Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;97:299-301
doi: 10.1161/01.RES.0000179774.56498.d2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leri, A.
Right arrow Articles by Kajstura, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leri, A.
Right arrow Articles by Kajstura, J.
(Circulation Research. 2005;97:299.)
© 2005 American Heart Association, Inc.


Editorials

Endothelial Progenitor Cells

Unexpected Disclosures

Annarosa Leri, Jan Kajstura

From the Cardiovascular Research Institute, Department of Medicine, New York Medical College, Valhalla.

Correspondence to Dr Annarosa Leri, Cardiovascular Research Institute, Vosburgh Pavilion, New York Medical College, Valhalla, NY 10595. E-mail annarosa_leri@nymc.edu



See related article, pages 314–322


Key Words: stem cells • vasculogenesis • myocardial regeneration


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The formation of coronary collateral vessels constitutes a compensatory adaptation of the heart to ischemia. This vascular response increases blood supply to the myocardium reducing the area of hypoxic damage and, ultimately, infarct size. The recruitment of collateral vessels within the coronary circulation is favored by multiple episodes of ischemia, which provide the stimuli necessary for the growth of vascular structures and increased blood flow. The degree of collateralization significantly influences the prognosis of an ischemic episode, which is more severe with diabetes, metabolic syndrome, or in the elderly, the patient population mostly affected by coronary artery disease.1 Originally, angiogenesis, ie, sprouting of vessels from the preexisting circulation, was considered the exclusive mechanism of vascular remodeling and growth. The identification of circulating endothelial progenitor cells (EPCs) has modified this view.2 Migration and homing of EPCs to ischemic regions leads to de novo formation of vascular structures. In analogy with vessel development in the embryo, this process has been called vasculogenesis. Also, circulating EPCs participate in reendothelization of damaged vessels, together with resident vascular progenitor cells.3

EPCs represent a heterogeneous cell population of multiple origins and distinct phenotypes, which are able to give rise to functionally competent endothelial cells.4 In the hierarchy established in the hematopoietic system, progenitors identify cells with lower differentiation potential than stem cells (SCs). However, EPCs possess degrees of stemness, which include self-renewal, clonogenicity, and differentiation capacity.4 EPCs represent various subsets of progenitor cells that have distinct phenotypes but share the ability to differentiate into mature endothelial . . . [Full Text of this Article]